CIC biomaGUNE is a non-profit research organization created to promote scientific research and technological innovation at the highest levels in the Basque Country following the BIOBASQUE policy in order to create a new business sector based on biosciences.
Title: Nanostructured ITO slides for Small Molecule Profiling and Imaging Mass Spectrometry of Metabolites and by SALDI-MS.
Authors: Lopez de Laorden C., Beloqui A., Yate L., Calvo J., Puigivila M., Llop J. and Reichardt N.C.
Journal: Anal. Chem. 2015, 87, 431-440
By carefully adjusting the sputtering...
Attractive iron oxide nanoparticles for clinical applications
18/03/2015Launch of the European Research, Development & Innovation Projects Unit - CIC biomaGUNE
12/03/2015Kick-off meeting of the H2020 Marie Skłodowska-Curie Research and Innovation Staff Exchanges (RISE) HYMADE coordinated by CIC biomaGUNE
10/03/2015CIC biomaGUNE participates at Imaginenano 2015, one of the largest European Events in Nanoscience & Nanotechnology
26/02/2015Niels Reichardt, Principal Investigator of the Glycotechnology group interviewed at "La Mecanica del Caracol" from Eitb Radio (Basque Country’s Radio). more
ESR Position in Nanoimmunology: Nanofunctionalisation of TLR4 agonists and antagonists -Platforms for enhanced delivery with multimodal imaging trackingApplications are invited for a 36 months position as early-stage researcher (ESR) to work on the Marie Skłodowska-Curie Innovative Training Network TOLLerant from May/June 2015. The research, which will be carried out at CIC biomaGUNE (San
Marie Curie postdoctoral possitionCIC bioma GUNE , San Sebastian, Spain has an opening for 2 years Marie Curie postdoctoral possition for an experienced researcher with 4-10 experience within the FP7-PEOPLE-2013-IAPP VIROMA. We are looking for a highly motivated post doctoral
ESR Position: PhD fellowship at CIC biomaGUNE, San Sebastian, SpainApplications are invited for a 36 months position as early-stage researcher (ESR) to work on the Marie Skłodowska-Curie Innovative Training Network IMMUNOSHAPE (Selective Carbohydrate Immunomodulators targeting C-type Lectin Receptors on Antigen more